Loading cancer entity…
Loading cancer entity…
Clinical trials
144 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06440122 | The Incidence and Outcomes of Metabolically Active Brown Adipose Tissue (aBAT) in Patients With Pheochromocytoma or Paraganglioma (PPGLs) | unknown | — | 100 | King's College Hospital NHS TrustOTHER | 1 | Jun 3, 2024 | clinicaltrials |
| NCT06229405 | Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data | unknown | — | 8,200 | Seoul National University HospitalOTHER | 1 | Mar 4, 2024 |
| clinicaltrials |
| NCT05418907 | Exendin PET/CT for Imaging of Paragangliomas(ENTRAP) | unknown | — | 10 | Radboud University Medical CenterOTHER | 1 | Dec 8, 2023 | clinicaltrials |
| NCT06155734 | Fluorescence Guided Minimally-Invasive Resection Of Abdominal Paragangliomas Using Indocyanine Green | unknown | — | 6 | Leiden University Medical CenterOTHER | 1 | Dec 4, 2023 | clinicaltrials |
| NCT06050057 | Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy | unknown | — | 100 | University Hospital OlomoucOTHER | 1 | Sep 22, 2023 | clinicaltrials |
| NCT06015061 | Prediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound PPGL Patients | unknown | — | 20 | Peking Union Medical College HospitalOTHER | 1 | Aug 29, 2023 | clinicaltrials |
| NCT05158712 | Genetic Factors and Pheochromocytomas in Neoplasia Type 2(NEM2A-Pheo) | unknown | — | 14 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05885399 | The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment | unknown | Phase 2 | 5 | Peking Union Medical College HospitalOTHER | 1 | Jun 2, 2023 | clinicaltrials |
| NCT05885386 | A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL | unknown | Phase 2 | 20 | Peking Union Medical College HospitalOTHER | 1 | Jun 1, 2023 | clinicaltrials |
| NCT05883085 | A Study on the Safety and Effectiveness of Anlotinib for Neoadjuvant Treatment of PPGL | unknown | Phase 2 | 10 | Peking Union Medical College HospitalOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05451134 | Predictors and Outcomes of Dysglycemia in Pheochromocytoma and Paraganglioma | unknown | — | 300 | China National Center for Cardiovascular DiseasesOTHER_GOV | 1 | Jul 12, 2022 | clinicaltrials |
| NCT04890444 | China Adrenal Disease Registry(CASE) | unknown | — | 2,000 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Feb 14, 2022 | clinicaltrials |
| NCT04891081 | Plasma Metanephrines in Patients With Cyanotic and Acyanotic Congenital Heart Disease | unknown | — | 50 | University Medical Centre LjubljanaOTHER | 1 | May 18, 2021 | clinicaltrials |
| NCT04017104 | Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging | unknown | — | 60 | British Columbia Cancer AgencyOTHER | 1 | Jan 26, 2021 | clinicaltrials |
| NCT00874614 | A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma | unknown | Phase 2 | 74 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 20, 2020 | clinicaltrials |
| NCT03158870 | Surgeon-Anesthesiologist Collaboration(CCAP) | unknown | — | 1,122 | Hospices Civils de LyonOTHER | 1 | May 18, 2017 | clinicaltrials |
| NCT01373736 | 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors | unknown | Phase 3 | — | Vancouver Coastal HealthOTHER_GOV | 1 | Jun 15, 2011 | clinicaltrials |
Data updated 22 days agoSource updated Jun 3, 2024source: clinicaltrials